The FDA has accepted for review the New Drug Application for a 25mg oral formulation of semaglutide for chronic weight management.

The chart below compares the cost of an annualized semaglutide dosage from Hims, versus competitors: The pivot to liraglutide will allow Hims & Hers to prolong its operations in the weight-loss ...

The shape of the AUC has implications for dosage conversions even if the 2.5:1 ratio applies for most patients. In other words, the total drug exposure as noted by the AUC may be similar for an i ...